Zelira Therapeutics Ltd
SWB:G1G
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Zelira Therapeutics Ltd (G1G) under the Base Case is EUR per share.
Compared with the current market price of 0.298 EUR, the stock appears .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What Zelira Therapeutics Does
Zelira Therapeutics Ltd. is a bio-pharmaceutical company, which engages in the research, development and commercialisation of cannabinoid-based formulations for the treatment of a variety of medical conditions. The firm is engaged in the research, development and commercialization of clinically validated cannabinoid-based medicines. The company owns a portfolio of products and a pipeline of candidates undergoing clinical development positioned to enter global markets.
- Headquarters
- Australia AU
- IPO date
- Jul 28, 2003
Earnings Waterfall
Zelira Therapeutics Ltd
What is the Intrinsic Value of one G1G stock?
The intrinsic value for Zelira Therapeutics Ltd (G1G) under the Base Case is EUR.
Is G1G stock undervalued or overvalued?
Compared with the current market price of 0.298 EUR, the stock appears .
